pentamidine has been researched along with AIDS-Related Opportunistic Infections in 202 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate combined prophylaxis for Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis, 533 patients with symptomatic human immunodeficiency virus infection and/or CD4 lymphocyte counts of < 200/microL were randomized to receive dapsone/pyrimethamine (200/75 mg once weekly) or aerosolized pentamidine (300 mg every 4 weeks)." | 9.08 | Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. ( Heald, A; Hirschel, B; Iten, A; Lazzarin, A; Oertle, D; Opravil, M; Pechère, M; Praz, G; Rüttimann, S; von Overbeck, J, 1995) |
| "The frequent occurrence of bronchospasm due to aerosolized pentamidine (AP) may reduce delivery of drugs to distal airways and produce symptoms that limit therapy." | 9.07 | Prophylaxis of aerosolized pentamidine-induced bronchospasm: a symptom-based approach. ( Jensen, WA; Kagawa, FT; Kirsch, CM; McSharry, RJ, 1993) |
| " However, the impact of PCP prophylaxis on the incidence of bacterial pneumonia in HIV-positive patients using pentamidine or co-trimoxazole is still unknown." | 7.70 | [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine]. ( Braun, J; Dalhoff, K; Friedrich, HJ; Kämmerer, R; Koch, A; Kothe, H, 1998) |
| "To report a case of probable pentamidine-induced acute pancreatitis." | 7.69 | Probable pentamidine-induced acute pancreatitis. ( Aguar, MC; Aran, X; Broquetas, JM; Gea, JG; Pastó, M; Sauleda, J, 1994) |
| "There have been 15 published cases of probable pentamidine-induced torsade de pointes (TdP)." | 7.69 | Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. ( Coyne, PE; Eisenhauer, MD; Eliasson, AH; Taylor, AJ; Wortham, DC, 1994) |
| "Dapsone was more effective in the primary prophylaxis of toxoplasmic encephalitis, with six toxoplasmic encephalitis events occurring among those receiving aerosolized pentamidine, compared to none among those taking dapsone (p = 0." | 6.67 | Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. ( Barr, M; Carlo, C; Chanin, E; Gregory, G; Kiely, S; Martin, M; Thorn, M; Thornton, J; Torres, RA, 1993) |
| "Of these admissions, 570 involved 637 bacterial infections diagnosed among patients who had been prescribed prophylactic TMP-SMX or aerosolized pentamidine." | 5.30 | Bacterial infections in adult patients hospitalized with AIDS: case-control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine. ( Holmes, KK; Hooton, TM; Koutsky, LA; Krone, MR; Tabet, SR, 1997) |
| "To evaluate combined prophylaxis for Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis, 533 patients with symptomatic human immunodeficiency virus infection and/or CD4 lymphocyte counts of < 200/microL were randomized to receive dapsone/pyrimethamine (200/75 mg once weekly) or aerosolized pentamidine (300 mg every 4 weeks)." | 5.08 | Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. ( Heald, A; Hirschel, B; Iten, A; Lazzarin, A; Oertle, D; Opravil, M; Pechère, M; Praz, G; Rüttimann, S; von Overbeck, J, 1995) |
| "The frequent occurrence of bronchospasm due to aerosolized pentamidine (AP) may reduce delivery of drugs to distal airways and produce symptoms that limit therapy." | 5.07 | Prophylaxis of aerosolized pentamidine-induced bronchospasm: a symptom-based approach. ( Jensen, WA; Kagawa, FT; Kirsch, CM; McSharry, RJ, 1993) |
| "The combination of clindamycin plus primaquine appears to be the most effective alternative treatment for patients with P carinii pneumonia who are unresponsive to conventional antipneumocystis agents." | 4.81 | A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. ( Maloba, B; Nagar, S; Popara, M; Smego, RA, 2001) |
| " Well-controlled studies of aerosolized antibiotics in cystic fibrosis demonstrate that tobramycin on a cyclical basis may reduce sputum volume, bacterial counts, and improve pulmonary function." | 4.80 | Inhaled antimicrobial therapy. ( Faris, M; O'Riordan, T, 1999) |
| "In a meta-analysis, we examined the efficacy of aerosolized pentamidine, trimethoprim-sulfamethoxazole, and dapsone or dapsone/pyrimethamine for the prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in patients with HIV infection." | 4.79 | Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. ( Bucher, HC; Griffith, L; Guyatt, GH; Opravil, M, 1997) |
| " For dapsone, among 100 patients given 100 mg daily instead of twice a week for 1 year (primary prophylaxis), seven fewer patients would develop P carinii pneumonia, but 17 more would have significant toxic reactions." | 4.79 | A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. ( Cappelleri, JC; Ioannidis, JP; Lau, J; Sacks, HS; Skolnik, PR, 1996) |
| "Pneumocystis carinii infection of the thyroid gland has previously been described in only four living patients with acquired immunodeficiency syndrome, three of whom had been receiving inhaled pentamidine prophylaxis against P carinii pneumonia." | 4.78 | Pneumocystis carinii thyroiditis. Report of three cases and review of the literature. ( Axline, SG; Greaves, TS; Guttler, R; McGill, JJ; Singer, PA, 1993) |
| "We report a retrospective and descriptive study of four immunocompromised patients (three with HIV-1 and one with idiopathic CD4+-lymphopenia) with relapsing visceral leishmaniasis seen at the Hospital for Tropical Diseases, London, in whom pentamidine was used as secondary prophylaxis to prevent relapse." | 3.75 | Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases. ( Lockwood, DN; Patel, TA, 2009) |
| " However, the impact of PCP prophylaxis on the incidence of bacterial pneumonia in HIV-positive patients using pentamidine or co-trimoxazole is still unknown." | 3.70 | [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine]. ( Braun, J; Dalhoff, K; Friedrich, HJ; Kämmerer, R; Koch, A; Kothe, H, 1998) |
| "To report a case of probable pentamidine-induced acute pancreatitis." | 3.69 | Probable pentamidine-induced acute pancreatitis. ( Aguar, MC; Aran, X; Broquetas, JM; Gea, JG; Pastó, M; Sauleda, J, 1994) |
| "There have been 15 published cases of probable pentamidine-induced torsade de pointes (TdP)." | 3.69 | Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. ( Coyne, PE; Eisenhauer, MD; Eliasson, AH; Taylor, AJ; Wortham, DC, 1994) |
| "Clinical trials have shown that the prophylactic use of zidovudine and aerosolized pentamidine (or other antibiotics used as prophylaxis against Pneumocystis carinii pneumonia) in acquired immunodeficiency syndrome (AIDS)-free human immunodeficiency virus (HIV)-infected persons delays the development of AIDS, but the effectiveness of such therapy in general use in the population still remains largely undocumented." | 3.68 | Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort. ( Clark, WS; Karon, JM; Longini, IM, 1993) |
| "To determine the relative distribution of Pneumocystis carinii in the lungs of patients with P carinii pneumonia and to see the effect of aerosol pentamidine prophylaxis on this distribution." | 3.68 | Increased Pneumocystis carinii recovery from the upper lobes in Pneumocystis pneumonia. The effect of aerosol pentamidine prophylaxis. ( Baughman, RP; Buchsbaum, JA; Dohn, MN; Frame, PT; Shipley, R, 1993) |
| "The prevention of cerebral toxoplasmosis and of Pneumocystis carinii pneumonia is an essential objective in the management of patients infected with HIV." | 2.68 | Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients. ( Carles, M; Dellamonica, P; Durant, J; Hazime, F; Pechere, JC, 1995) |
| "Pentamidine was measured using a chromatographic (HPLC) assay." | 2.68 | Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus. ( Conte, JE; Golden, JA, 1995) |
| "Primary prophylaxis against Pneumocystis carinii pneumonia (PCP) for patients with HIV infection has been recommended by the Centers for Disease Control and Prevention." | 2.67 | Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity. ( Berglund, O; Elvin, K; Lidman, C; Lindbäck, S; Tynell, E, 1994) |
| "Dapsone was more effective in the primary prophylaxis of toxoplasmic encephalitis, with six toxoplasmic encephalitis events occurring among those receiving aerosolized pentamidine, compared to none among those taking dapsone (p = 0." | 2.67 | Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. ( Barr, M; Carlo, C; Chanin, E; Gregory, G; Kiely, S; Martin, M; Thorn, M; Thornton, J; Torres, RA, 1993) |
| "Participants were AIDS patients with no history of PCP, patients with a CD4 count < or = 0." | 2.67 | Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled, randomized trial. ( Backer, V; Flaschs, H; Gaub, J; Højlyng, N; Jensen, BN; Mathiesen, L; Nelsing, S; Nielsen, JO; Nielsen, TL; Simonsen, L, 1993) |
| "Nineteen episodes of cerebral toxoplasmosis were diagnosed during the study." | 2.67 | Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses. ( Beuscart, C; Borsa Lebas, F; Canton, P; Leclercq, P; Marchou, B; May, T; Micoud, M; Mouton, Y; Reynes, J; Saba, J, 1994) |
| "The data suggest, but do not prove, that a dose-response effect has been demonstrated, and that high-dose aerosolized pentamidine may further reduce the attack rate of PCP." | 2.67 | A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis. ( Chernoff, DN; Conte, JE; Duncan, SM; Golden, JA; Katz, MH, 1993) |
| "Primary prophylaxis against Pneumocystis carinii pneumonia (PCP) is recommended for patients with human immunodeficiency virus (HIV) infection if their CD4 cell counts are below 200 per cubic millimeter (0." | 2.67 | A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. ( Borleffs, JC; Eeftinck Schattenkerk, JK; Frissen, JP; Hoepelman, AI; Kolsters, AF; Nielsen, TL; Schneider, MM; van der Ende, IM; van der Graaf, Y, 1992) |
| "Prophylaxis against Pneumocystis carinii pneumonia (PCP) and candida were given routinely." | 2.67 | Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program. ( Brandwein, J; Burkes, RL; Sawka, CA; Shepherd, FA; Sutton, DM; Warner, E, 1992) |
| "The estimated recurrence rates at 18 months were 11." | 2.67 | A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. ( Fass, RJ; Feinberg, J; Finkelstein, DM; Frame, PT; Hardy, WD; He, W; Holmes, M; Kaczka, C; Power, ME; Waskin, H, 1992) |
| " There was no significant difference in the occurrence of serious adverse reactions (six in the dapsone and eight in the pentamidine arm)." | 2.67 | Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity. ( Hoy, JF; Kent, SJ; Lucas, CR; Pettinger, MB; Slavin, MA; Stewart, K, 1992) |
| " In spite of the high number of reported cases of HIV-related VL, the treatment of choice, the best dosage and the duration of therapy appear not to be properly established." | 2.41 | Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences. ( Ali, A, 2002) |
| "The clinical presentation and treatment of acute pancreatitis in HIV-infected patients are also reviewed." | 2.40 | Acute pancreatitis in human immunodeficiency virus-infected patients: a review. ( Dassopoulos, T; Ehrenpreis, ED, 1999) |
| "Although the incidence of Pneumocystis carinii pneumonia (PCP) among adults infected with human immunodeficiency virus (HIV) has declined, no decline in PCP incidence has been observed among HIV-infected children, and PCP remains the most common serious opportunistic infection among both adults and children in the United States." | 2.39 | Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. ( Feinberg, J; Hughes, WT; Navin, TR; Simonds, RJ, 1995) |
| "Pentamidine is a drug generally used for the prophylactic treatment of Pneumocystis pneumonia in immunocompromised patients." | 1.38 | [Use of pentamidine nebulization in children]. ( Chaumuzeau, JP; Diot, P; Dubus, JC; Oudyi, M, 2012) |
| "Pneumothorax has been reported in several cases." | 1.37 | Fatal bilateral pneumothoraces following administration of aerosolised pentamidine. ( Green, A; Milne, N; Ong, BB, 2011) |
| "Pulmonary nocardiosis should be considered as a differential diagnosis of recurring pneumonia in immunocompromised patients, especially in HIV-infected individuals." | 1.37 | Pulmonary nocardiosis caused by Nocardia exalbida complicating Pneumocystis pneumonia in an HIV-infected patient. ( Fujii, T; Gonoi, T; Imai, K; Iwamoto, A; Kikuchi, T; Koga, M; Koibuchi, T; Miura, T; Nakamura, H; Yazawa, K, 2011) |
| "Pentamidine was associated with a greater risk of death when used as first- and second-line therapy for HIV-associated PCP, and was associated with more treatment changes." | 1.35 | Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. ( Atzori, C; Benfield, T; Helweg-Larsen, J; Miller, RF, 2009) |
| "The high incidence of P carinii pneumonia in persons infected with human immunodeficiency virus (HIV) has served to focus laboratory and clinical research efforts on better understanding the biology of the organism and on improving diagnosis, treatment, and prevention of this disease." | 1.31 | New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. ( Gill, VJ; Kovacs, JA; Masur, H; Meshnick, S, 2001) |
| "A total of 29 patients with AIDS and PCP who were admitted to the AIDS Clinical Center, International Medical Center of Japan from July 1996 to November 1999." | 1.31 | Complications during clinical courses of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. ( Genka, I; Kikuchi, Y; Oka, S; Tachikawa, N; Teruya, K; Yamaguchi, M; Yamamoto, Y; Yasuoka, A; Yasuoka, C, 2001) |
| " Dosing or frequency of TMP-SMX did not seem to influence risk of chemoprophylaxis failure." | 1.30 | Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators. ( Holmberg, SD; Moorman, AC; Palella, FJ; Von Bargen, JC, 1998) |
| "017), cumulative dosage of pentamidine (OR = 1." | 1.30 | A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia. ( Balano, KB; Coleman, RL; Dong, BJ; Gee, L; O'Brien, JG, 1997) |
| "Spontaneous pneumothorax is a relatively frequent complication of human immunodeficiency virus (HIV) infection." | 1.30 | [Spontaneous pneumothorax associated with human immunodeficiency virus (HIV) infection]. ( Cifrián Martínez, JM; Fernández Rozas, SM; García Pérez, MM; Golpe Gómez, R; Jiménez Gómez, A; Mons Lera, R, 1998) |
| "aureus bacteremia were compared against 188 controls selected from patients with CD4 cell counts < 200 x 10(6)/l." | 1.30 | Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients. ( Chaisson, RE; Moore, RD; Styrt, BA, 1997) |
| "Of these admissions, 570 involved 637 bacterial infections diagnosed among patients who had been prescribed prophylactic TMP-SMX or aerosolized pentamidine." | 1.30 | Bacterial infections in adult patients hospitalized with AIDS: case-control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine. ( Holmes, KK; Hooton, TM; Koutsky, LA; Krone, MR; Tabet, SR, 1997) |
| "Pneumocystis carinii prophylaxis in AIDS patients might be safety withdrawn after effective HAART." | 1.30 | [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases]. ( de Górgolas Hernández, M; Fernández Guerrero, ML; García Delgado, R; García Vázquez, E, 1999) |
| " Overall results from these studies indicate patients who are eligible for PCP prophylaxis should be advised to take double-strength trimethoprim/sulfamethoxazole (TMP/SMX) on a daily basis, a dosage found more effective than thrice-weekly." | 1.30 | Optimizing PCP therapy. ( Cadman, J; Torres, G, 1997) |
| "The risk to develop cerebral toxoplasmosis appeared significantly higher in the group of patients who stopped sulfamethoxazole-trimethoprim consecutively to cutaneous hypersensitivity." | 1.30 | [Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole]. ( Beuscart, C; Canton, P; Leport, C; May, T; Rabaud, C; Reynes, J, 1998) |
| "To determine the use of AIDS drugs and therapies by populations with relatively good access to health care." | 1.29 | Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities. ( Buchbinder, SP; Bush, TJ; Conley, LJ; Hershow, RC; Holmberg, SD; Judson, FN; Katz, MH; Penley, KA, 1993) |
| "No extrapulmonary or disseminated pneumocystosis was observed in either group." | 1.29 | Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia. ( Ewig, S; Lüderitz, B; Pickenhain, A; Rockstroh, JK; Schäfer, H, 1996) |
| "Bacteremia was caused by Staphylococcus aureus (23%), Pseudomonas aeruginosa (18%), Escherichia coli (16%), Streptococcus pneumoniae (14%) and others (31%)." | 1.29 | Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. ( Edge, MD; Rimland, D, 1996) |
| "PCP was the leading AIDS manifestation (21." | 1.29 | Pneumocystis carinii infections in HIV-infected hemophiliacs during aerosolized pentamidine prophylaxis. ( Brackmann, HH; Christ, F; Ewig, S; Lüchters, G; Lüderitz, B; Marklein, G; Rockstroh, JK; Seitz, HM, 1993) |
| "A total of 25 cases of Pneumocystis carinii pneumonia was observed (3." | 1.29 | [Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations]. ( Albrecht, H; Begemann, F; Meigel, W; Plettenberg, A; Stellbrink, HJ; Stoehr, A, 1994) |
| " The infant's dose of pentamidine was based on an adult dosage of 300 to 600 mg/month, adjusted for minute ventilation and weight." | 1.29 | Aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in infants with human immunodeficiency virus infection. ( Caspe, WB; Hand, IL; Lambert, G; Porricolo, M; Wiznia, AA, 1994) |
| "Pneumocystis carinii pneumonia is frequent in patients with cellular immunity impairments, specially those with AIDS." | 1.29 | [Pneumonia caused by Pneumocystis carinii in immunodepressed patients: clinical picture, treatment, and prognosis]. ( Acuña, G; Almendarez, C; de la Cerda, G; Labarca, J; Oddó, D; Pérez, C; Sirhan, M, 1994) |
| "carinii prophylaxis before the onset of AIDS: Mycobacterium avium complex disease, which developed in 33." | 1.29 | Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. ( Anderson, R; Bacellar, H; Detels, R; Hoover, DR; Kaslow, RA; Phair, J; Saah, AJ, 1993) |
| "Diverse glucose abnormalities exist in AIDS." | 1.29 | Transient state of NIDDM in a patient with AIDS. ( Abourizk, NN; Lyons, RW; Madden, GM, 1993) |
| "Pentamidine aerosols were prescribed for 456 HIV-positive patients as primary or secondary prophylaxis." | 1.29 | [Prevention of Pneumocystis carinii pneumonia associated with HIV infection using pentamidine aerosols. Retrospective study of 465 cases]. ( Chauvelle, MT; Dupont, B; Feuillie, V; Guinet, F; Pialoux, G; Sansonetti, P; Trotot, P, 1994) |
| " Intramuscular pentamidine was given monthly by the Z-track technique at a dosage of 300 mg (4 mg/kg if the patient weighed < 50 kg)." | 1.29 | Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. ( Cheung, TW; Chusid, E; Hammer, G; Matta, R; Neibart, E; Rose, D; Sacks, HS; Szabo, S, 1993) |
| " pentamidine in a dosage of either 300 mg once a month for prophylaxis or 4 mg/kg/d 5 days a week for treatment of Pneumocystis carinii pneumonia (PCP)." | 1.29 | The safety of i.v. pentamidine administered in an ambulatory setting. ( Chan, CK; Chan, M; Yeung, KT, 1996) |
| "Occurrence or recurrence of PCP." | 1.29 | Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. ( Hoover, DR; Kingsley, LA; Peng, Y; Phair, JP; Saah, AJ; Schrager, LK; Visscher, B, 1995) |
| "Despite the difference in dosage (120 mg/mo vs 300 mg/mo), type of nebulizer (ultrasonic vs jet), and frequency of administration (twice vs once monthly), the results of this study indicate that both regimens of AP provide comparable protection against PCP." | 1.29 | An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group. ( Berger, P; Chan, CK; McIvor, RA; Pack, LL; Rachlis, A, 1996) |
| "Pentamidine is known to cause severe dysglycaemia by damaging beta-cell function of the pancreas." | 1.29 | Insulin-dependent diabetes mellitus following pentamidine therapy in a patient with AIDS. ( Bogner, JR; Goebel, FD; Liegl, U, 1994) |
| "The pentamidine-treated dysglycemic patients differed from their euglycemic counterparts by higher pentamidine doses (P < 0." | 1.29 | Pentamidine-induced derangements of glucose homeostasis. Determinant roles of renal failure and drug accumulation. A study of 128 patients. ( Assan, D; Assan, R; Chotard, L; Matheron, S; Mayaud, C; Perronne, C; Zucman, D, 1995) |
| "Pentamidine was not detected in the urine of any of the subjects." | 1.29 | Respiratory effects of occupational exposure to aerosolized pentamidine. ( Balmes, JR; Blanc, P; Corkery, K; Estacio, PL; Kelly, T; Quinlan, P, 1995) |
| "We report a case of splenic pneumocystosis in a human immunodeficiency virus-positive individual treated prophylactically with aerosolized pentamidine." | 1.29 | [Extra-pulmonary pneumocystosis in the course of AIDS. Report of a case]. ( Marche, C; Potet, F; Terris, B, 1996) |
| "Extrapulmonary localizations of pneumocystosis were noticed (eye, liver, spleen, ascitis) in two AP+." | 1.29 | [Pneumocystis carinii pneumonia in AIDS: retrospective analysis of 80 documented cases (1985-1993)]. ( Aubertin, J; Bartou, C; Bernard, N; Beylot, J; Buisson, M; Couprie, B; Dequae, L; Lacoste, D; Mercié, P; Morlat, P; Ragnaud, JM, 1996) |
| "Pneumocystis carinii pneumonia was common in advanced HIV infection treated with zidovudine." | 1.28 | Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group. ( Chaisson, RE; Keruly, J; Moore, RD; Richman, DD, 1992) |
| "Choroiditis was a preterminal diagnosis for three patients--two with associated disseminated pneumocystosis." | 1.28 | Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcome. ( Benson, CA; Deutsch, T; Finn, WG; Kessler, HA; Murphy, RL; Noskin, GA; Pottage, JC; Roth, SI; Sha, BE, 1992) |
| "A 14-year-old male HIV-positive hemophilia A patient, who was complicated by disseminated intravascular coagulation syndrome (DIC) following acute pancreatitis during treatment for PCP, was treated with proteinase inhibitors and anticoagulant agents." | 1.28 | [HIV-1 seropositive hemophilia A complicated by disseminated intravascular coagulation syndrome and acute pancreatitis during treatment of Pneumocystis carinii pneumonia]. ( Fukue, H; Koshihara, K; Matsumoto, K; Suzuki, T; Takahashi, Y; Tanaka, A; Tateyama, M; Yamagishi, T; Yorifuji, H; Yoshida, S, 1992) |
| "The optimal dosage of pentamidine for prophylaxis of Pneumocystis carinii pneumonia (PcP) is unknown." | 1.28 | Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks. ( Bogner, JR; Goebel, FD; Kronawitter, U, 1992) |
| "Group A consisted of AIDS patients (n = 7) who had had Pneumocystis carinii pneumonia (PCP), group B of AIDS patients (n = 7) not known to have had PCP, and group C of asymptomatic HIV-positive patients (n = 7)." | 1.28 | Bronchial responsiveness in AIDS patients with Pneumocystis carinii pneumonia. ( Hanley, SP; Mandal, BK; Ong, EL, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 169 (83.66) | 18.2507 |
| 2000's | 25 (12.38) | 29.6817 |
| 2010's | 7 (3.47) | 24.3611 |
| 2020's | 1 (0.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardy, RL | 1 |
| Tanious, FA | 1 |
| Ramachandran, K | 1 |
| Tidwell, RR | 1 |
| Wilson, WD | 1 |
| Chechi, F | 1 |
| Corsi, P | 1 |
| Bartolozzi, D | 1 |
| Gaiera, G | 1 |
| Bartoloni, A | 1 |
| Zammarchi, L | 1 |
| Diro, E | 1 |
| Ritmeijer, K | 1 |
| Boelaert, M | 1 |
| Alves, F | 1 |
| Mohammed, R | 1 |
| Abongomera, C | 1 |
| Ravinetto, R | 1 |
| De Crop, M | 1 |
| Fikre, H | 1 |
| Adera, C | 1 |
| Colebunders, R | 1 |
| van Loen, H | 1 |
| Menten, J | 1 |
| Lynen, L | 1 |
| Hailu, A | 1 |
| van Griensven, J | 1 |
| O'Neal, CB | 1 |
| Ball, SC | 1 |
| García-Lázaro, M | 1 |
| Villar, C | 1 |
| Natera, C | 1 |
| Rivero, A | 2 |
| Patel, TA | 1 |
| Lockwood, DN | 1 |
| Rybniker, J | 1 |
| Goede, V | 1 |
| Mertens, J | 1 |
| Ortmann, M | 1 |
| Kulas, W | 1 |
| Kochanek, M | 1 |
| Benzing, T | 1 |
| Arribas, JR | 1 |
| Fätkenheuer, G | 1 |
| Helweg-Larsen, J | 2 |
| Benfield, T | 2 |
| Atzori, C | 2 |
| Miller, RF | 2 |
| Pua, U | 1 |
| Imai, K | 1 |
| Koibuchi, T | 1 |
| Kikuchi, T | 1 |
| Koga, M | 1 |
| Nakamura, H | 1 |
| Miura, T | 1 |
| Gonoi, T | 1 |
| Yazawa, K | 1 |
| Iwamoto, A | 2 |
| Fujii, T | 1 |
| Borde, JP | 1 |
| Offensperger, WB | 1 |
| de With, K | 1 |
| Green, A | 1 |
| Milne, N | 1 |
| Ong, BB | 1 |
| Lim, PL | 1 |
| Zhou, J | 1 |
| Ditangco, RA | 1 |
| Law, MG | 1 |
| Sirisanthana, T | 1 |
| Kumarasamy, N | 1 |
| Chen, YM | 1 |
| Phanuphak, P | 1 |
| Lee, CK | 1 |
| Saphonn, V | 1 |
| Oka, S | 2 |
| Zhang, F | 1 |
| Choi, JY | 1 |
| Pujari, S | 1 |
| Kamarulzaman, A | 1 |
| Li, PC | 1 |
| Merati, TP | 1 |
| Yunihastuti, E | 1 |
| Messerschmidt, L | 1 |
| Sungkanuparph, S | 1 |
| Oudyi, M | 1 |
| Chaumuzeau, JP | 1 |
| Diot, P | 1 |
| Dubus, JC | 1 |
| Konishi, M | 2 |
| Amimoto, M | 1 |
| Yoshimoto, E | 2 |
| Takahashi, K | 2 |
| Mori, K | 1 |
| Mikasa, K | 2 |
| Narita, N | 2 |
| Nakamura, T | 2 |
| Ali, A | 1 |
| Uno, K | 1 |
| Kasahara, K | 1 |
| Murakawa, K | 1 |
| Maeda, K | 1 |
| Rodriguez, M | 1 |
| Fishman, JA | 1 |
| Couppié, P | 2 |
| Clyti, E | 2 |
| Sobesky, M | 1 |
| Bissuel, F | 1 |
| Del Giudice, P | 1 |
| Sainte-Marie, D | 1 |
| Dedet, JP | 1 |
| Carme, B | 2 |
| Pradinaud, R | 2 |
| Mitchell, B | 1 |
| López-Medrano, F | 1 |
| Costa, JR | 1 |
| Rodriguez-Peralto, JL | 1 |
| Aguado, JM | 1 |
| Loue, S | 1 |
| Slymen, DJ | 1 |
| Morgenstern, H | 1 |
| Whalen, C | 1 |
| Olree, K | 1 |
| Stein-Gocken, J | 1 |
| Siddiqui, MA | 1 |
| Ford, PA | 1 |
| Schwebke, K | 1 |
| Fletcher, CV | 1 |
| Acosta, EP | 1 |
| Henry, K | 1 |
| Lustig, V | 1 |
| Kager, PA | 1 |
| Meenhorst, PL | 1 |
| Uzzan, B | 1 |
| Bentata, M | 1 |
| Campos, J | 1 |
| Mosnier, A | 1 |
| Krivitzky, A | 1 |
| Perret, GY | 1 |
| Modigliani, E | 1 |
| Hoernle, EH | 1 |
| Reid, TE | 1 |
| Balmes, JR | 1 |
| Estacio, PL | 1 |
| Quinlan, P | 1 |
| Kelly, T | 1 |
| Corkery, K | 1 |
| Blanc, P | 1 |
| Salmon-Ceron, D | 1 |
| Fontbonne, A | 1 |
| Saba, J | 2 |
| May, T | 3 |
| Raffi, F | 1 |
| Chidiac, C | 1 |
| Patey, O | 1 |
| Aboulker, JP | 1 |
| Schwartz, D | 1 |
| Vildé, JL | 1 |
| Montgomery, AB | 1 |
| Feigal, DW | 1 |
| Sattler, F | 1 |
| Mason, GR | 1 |
| Catanzaro, A | 1 |
| Edison, R | 1 |
| Markowitz, N | 1 |
| Johnson, E | 1 |
| Ogawa, S | 1 |
| Rovzar, M | 1 |
| Assan, R | 1 |
| Perronne, C | 1 |
| Assan, D | 1 |
| Chotard, L | 1 |
| Mayaud, C | 1 |
| Matheron, S | 1 |
| Zucman, D | 1 |
| Saah, AJ | 2 |
| Hoover, DR | 2 |
| Peng, Y | 1 |
| Phair, JP | 1 |
| Visscher, B | 1 |
| Kingsley, LA | 1 |
| Schrager, LK | 1 |
| Wilkinson, SB | 1 |
| Liegl, U | 1 |
| Bogner, JR | 4 |
| Goebel, FD | 3 |
| Albrecht, H | 3 |
| Sobottka, I | 1 |
| Stellbrink, HJ | 3 |
| Greten, H | 2 |
| Opravil, M | 3 |
| Hirschel, B | 1 |
| Lazzarin, A | 3 |
| Heald, A | 1 |
| Pechère, M | 1 |
| Rüttimann, S | 1 |
| Iten, A | 1 |
| von Overbeck, J | 1 |
| Oertle, D | 1 |
| Praz, G | 1 |
| Bessesen, MT | 1 |
| Miller, LA | 1 |
| Cohn, DL | 1 |
| Bartlett, S | 1 |
| Ellison, RT | 1 |
| Martínez, MJ | 1 |
| de Otero, J | 1 |
| Vallano, A | 1 |
| Ribera, E | 1 |
| Durant, J | 1 |
| Hazime, F | 1 |
| Carles, M | 1 |
| Pechere, JC | 1 |
| Dellamonica, P | 1 |
| Brivet, FG | 1 |
| Naveau, SH | 1 |
| Lemaigre, GF | 1 |
| Dormont, J | 2 |
| Lecuit, M | 1 |
| Livartowski, J | 1 |
| Vons, C | 1 |
| Goujard, C | 1 |
| Lemaigre, G | 1 |
| Delfraissy, JF | 1 |
| Guinet, F | 1 |
| Pialoux, G | 1 |
| Trotot, P | 1 |
| Chauvelle, MT | 1 |
| Feuillie, V | 1 |
| Sansonetti, P | 1 |
| Dupont, B | 1 |
| Sabin, C | 1 |
| Pasi, J | 1 |
| Phillips, A | 1 |
| Elford, J | 1 |
| Janossy, G | 1 |
| Lee, C | 1 |
| Clumeck, N | 1 |
| Bozzette, SA | 2 |
| Finkelstein, DM | 3 |
| Spector, SA | 1 |
| Frame, P | 1 |
| Powderly, WG | 1 |
| He, W | 2 |
| Phillips, L | 1 |
| Craven, D | 1 |
| van der Horst, C | 1 |
| Feinberg, J | 3 |
| Hughes, WT | 2 |
| Veyssier, P | 1 |
| Cevallos, R | 1 |
| Le Fouillé-Ribeyre, C | 1 |
| Geffray, L | 1 |
| Kaloustian, E | 1 |
| Farinotti, R | 1 |
| Dohn, MN | 2 |
| Weinberg, WG | 1 |
| Torres, RA | 2 |
| Follansbee, SE | 1 |
| Caldwell, PT | 1 |
| Scott, JD | 1 |
| Gathe, JC | 1 |
| Haghighat, DP | 1 |
| Sampson, JH | 1 |
| Spotkov, J | 1 |
| Deresinski, SC | 2 |
| Meyer, RD | 1 |
| Lancaster, DJ | 1 |
| Nasti, G | 1 |
| Zanette, G | 1 |
| Inchiostro, S | 1 |
| Donadon, V | 1 |
| Tirelli, U | 1 |
| Bacellar, H | 1 |
| Phair, J | 1 |
| Detels, R | 1 |
| Anderson, R | 1 |
| Kaslow, RA | 1 |
| Jablonowski, H | 1 |
| Sander, O | 1 |
| Willers, R | 1 |
| Adams, O | 1 |
| Bartmann, P | 1 |
| Wahn, V | 1 |
| Barchiesi, F | 1 |
| Del Poeta, M | 1 |
| Morbiducci, V | 1 |
| Ancarani, F | 1 |
| Scalise, G | 1 |
| Luchon, L | 1 |
| Couderc, LJ | 1 |
| Stern, M | 1 |
| Friard, S | 1 |
| Caubarrere, I | 1 |
| Lidman, C | 1 |
| Berglund, O | 1 |
| Tynell, E | 1 |
| Lindbäck, S | 1 |
| Elvin, K | 1 |
| Laguna, F | 2 |
| García-Samaniego, J | 1 |
| Soriano, V | 3 |
| Valencia, E | 1 |
| Redondo, C | 1 |
| Alonso, MJ | 1 |
| González-Lahoz, JM | 2 |
| Santos Gil, I | 1 |
| Jaras Hernández, M | 1 |
| Contini, C | 1 |
| Romani, R | 1 |
| Vullo, V | 1 |
| Delia, S | 1 |
| Sorice, F | 1 |
| Barr, M | 1 |
| Thorn, M | 1 |
| Gregory, G | 1 |
| Kiely, S | 1 |
| Chanin, E | 1 |
| Carlo, C | 1 |
| Martin, M | 1 |
| Thornton, J | 1 |
| Tocchetti, A | 1 |
| Tambini, R | 1 |
| Allegro, A | 1 |
| Longoni, E | 1 |
| Rinaldi, E | 1 |
| Schuval, SJ | 1 |
| Bonagura, VR | 1 |
| Pérez, C | 1 |
| Almendarez, C | 1 |
| Oddó, D | 1 |
| Sirhan, M | 1 |
| Labarca, J | 1 |
| Acuña, G | 1 |
| de la Cerda, G | 1 |
| Casale, L | 1 |
| Gold, H | 1 |
| Schechter, C | 1 |
| Naficy, A | 1 |
| Masci, JR | 1 |
| Jensen, BN | 2 |
| Nielsen, TL | 3 |
| Backer, V | 1 |
| Nelsing, S | 2 |
| Simonsen, L | 1 |
| Flaschs, H | 1 |
| Gaub, J | 1 |
| Højlyng, N | 1 |
| Nielsen, JO | 2 |
| Mathiesen, L | 1 |
| Longini, IM | 1 |
| Clark, WS | 1 |
| Karon, JM | 1 |
| Riquet, M | 1 |
| Chouaid, C | 1 |
| Saab, M | 1 |
| Hubsch, JP | 1 |
| Guillon, JM | 1 |
| Klotz, BL | 1 |
| Carnot, F | 1 |
| Sauleda, J | 1 |
| Gea, JG | 1 |
| Aguar, MC | 1 |
| Aran, X | 1 |
| Pastó, M | 1 |
| Broquetas, JM | 1 |
| Beuscart, C | 2 |
| Reynes, J | 2 |
| Marchou, B | 1 |
| Leclercq, P | 1 |
| Borsa Lebas, F | 1 |
| Micoud, M | 1 |
| Mouton, Y | 1 |
| Canton, P | 2 |
| Weiss, PJ | 1 |
| Wallace, MR | 1 |
| Hand, IL | 2 |
| Wiznia, AA | 1 |
| Porricolo, M | 1 |
| Lambert, G | 1 |
| Caspe, WB | 1 |
| Katial, R | 1 |
| Honeycutt, W | 1 |
| Oswald, SG | 1 |
| Stoehr, A | 1 |
| Plettenberg, A | 1 |
| Meigel, W | 1 |
| Begemann, F | 1 |
| Ewig, S | 3 |
| Rockstroh, JK | 3 |
| Seitz, HM | 1 |
| Marklein, G | 1 |
| Christ, F | 1 |
| Lüchters, G | 1 |
| Brackmann, HH | 1 |
| Lüderitz, B | 3 |
| Belsito, DV | 1 |
| Moreno, I | 1 |
| Gonzalo, MA | 1 |
| Fernández Guerrero, M | 1 |
| Herrera-Pombo, JL | 1 |
| Wiznia, A | 1 |
| Porricola, M | 1 |
| Ajisawa, A | 2 |
| Mayer, HB | 1 |
| Rose, DN | 1 |
| Cohen, S | 1 |
| Gurtman, AC | 1 |
| Cheung, TW | 2 |
| Szabo, S | 2 |
| Lalonde, L | 1 |
| Allaire, GS | 1 |
| Sebag, M | 1 |
| Lamer, L | 1 |
| Marcil, G | 1 |
| Gervais, A | 2 |
| Anastasi, JK | 1 |
| Rivera, J | 1 |
| Eisenhauer, MD | 1 |
| Eliasson, AH | 1 |
| Taylor, AJ | 1 |
| Coyne, PE | 1 |
| Wortham, DC | 1 |
| Holmberg, SD | 2 |
| Conley, LJ | 1 |
| Buchbinder, SP | 1 |
| Judson, FN | 1 |
| Bush, TJ | 1 |
| Katz, MH | 2 |
| Penley, KA | 1 |
| Hershow, RC | 1 |
| Abourizk, NN | 1 |
| Lyons, RW | 1 |
| Madden, GM | 1 |
| McSharry, RJ | 1 |
| Kirsch, CM | 1 |
| Jensen, WA | 1 |
| Kagawa, FT | 1 |
| Meeker, DP | 1 |
| Matysik, GA | 1 |
| Stelmach, K | 1 |
| Rehm, S | 1 |
| Tu, JV | 1 |
| Biem, HJ | 1 |
| Detsky, AS | 1 |
| Golden, JA | 2 |
| Chernoff, DN | 1 |
| Duncan, SM | 1 |
| Conte, JE | 2 |
| Sylla, G | 1 |
| Kullean, N | 1 |
| Lafferre, A | 1 |
| Mussard, F | 1 |
| Rossi, P | 1 |
| Lang, W | 1 |
| Osmond, D | 1 |
| Page-Bodkin, K | 1 |
| Moss, A | 1 |
| Winkelstein, W | 1 |
| Martinez, M | 1 |
| González-Lahoz, J | 1 |
| Weintrub, PS | 1 |
| Wara, DW | 1 |
| Duliege, AM | 1 |
| Brooks, KR | 1 |
| Ong, R | 1 |
| Spector, RS | 1 |
| Greenbaum, DM | 1 |
| Guttler, R | 1 |
| Singer, PA | 1 |
| Axline, SG | 1 |
| Greaves, TS | 1 |
| McGill, JJ | 1 |
| Baughman, RP | 1 |
| Shipley, R | 1 |
| Buchsbaum, JA | 1 |
| Frame, PT | 2 |
| Mallolas, J | 1 |
| Zamora, L | 1 |
| Gatell, JM | 1 |
| Miró, JM | 1 |
| Vernet, E | 1 |
| Valls, ME | 1 |
| Soriano, E | 1 |
| SanMiguel, JG | 1 |
| Matta, R | 1 |
| Neibart, E | 1 |
| Hammer, G | 1 |
| Chusid, E | 1 |
| Sacks, HS | 2 |
| Rose, D | 1 |
| Gaur, S | 1 |
| Rosenthal, S | 1 |
| Dadhania, J | 1 |
| Lupski, D | 1 |
| Mascarhenas, M | 1 |
| Amenta, PS | 1 |
| Bharucha, N | 1 |
| Cappell, MS | 1 |
| Fenske, S | 1 |
| Koch, J | 1 |
| Thalhammer, C | 1 |
| Lohmöller, G | 1 |
| Nardini, S | 1 |
| Girard, PM | 1 |
| Landman, R | 1 |
| Gaudebout, C | 2 |
| Olivares, R | 1 |
| Saimot, AG | 1 |
| Jelazko, P | 1 |
| Certain, A | 1 |
| Boué, F | 1 |
| Bouvet, E | 1 |
| Ong, EL | 3 |
| Mandal, BK | 2 |
| Ng, VL | 1 |
| Geaghan, SM | 2 |
| Leoung, G | 1 |
| Shiboski, S | 1 |
| Fahy, J | 1 |
| Schnapp, L | 1 |
| Yajko, DM | 1 |
| Hopewell, PC | 2 |
| Hadley, WK | 1 |
| Bazin, C | 1 |
| Hazera, P | 1 |
| Greder, A | 1 |
| Cren, P | 1 |
| Lechevalier, B | 1 |
| Gallet, E | 1 |
| Charbonneau, P | 1 |
| Teuscher, AU | 1 |
| Theiler, R | 1 |
| Speich, R | 1 |
| Kuster, H | 1 |
| Siegenthaler, W | 1 |
| Russi, EW | 1 |
| Lüthy, R | 1 |
| Martos, A | 1 |
| Podzamczer, D | 1 |
| Martinez-Lacasa, J | 1 |
| Rufi, G | 1 |
| Santin, M | 1 |
| Gudiol, F | 1 |
| Boldorini, R | 1 |
| Guzzetti, S | 1 |
| Meroni, L | 1 |
| Quirino, T | 1 |
| Cristina, S | 1 |
| Monga, G | 1 |
| Mathiesen, LR | 1 |
| Skinhøj, P | 1 |
| Ioannidis, JP | 3 |
| Cappelleri, JC | 1 |
| Skolnik, PR | 1 |
| Lau, J | 2 |
| Simonds, RJ | 1 |
| Navin, TR | 1 |
| Lu, CP | 1 |
| Wu, HP | 1 |
| Chuang, LM | 1 |
| Lin, BJ | 1 |
| Chuang, CY | 1 |
| Tai, TY | 1 |
| Korraa, H | 1 |
| Saadeh, C | 1 |
| Antinori, A | 3 |
| Murri, R | 2 |
| Ammassari, A | 1 |
| De Luca, A | 3 |
| Linzalone, A | 1 |
| Cingolani, A | 1 |
| Damiano, F | 1 |
| Maiuro, G | 1 |
| Vecchiet, J | 1 |
| Scoppettuolo, G | 1 |
| Terris, B | 1 |
| Marche, C | 1 |
| Potet, F | 1 |
| Morlat, P | 1 |
| Bartou, C | 1 |
| Ragnaud, JM | 1 |
| Dequae, L | 1 |
| Lacoste, D | 1 |
| Buisson, M | 1 |
| Bernard, N | 1 |
| Mercié, P | 1 |
| Couprie, B | 1 |
| Beylot, J | 1 |
| Aubertin, J | 1 |
| Principi, N | 1 |
| Marchisio, P | 1 |
| Onorato, J | 1 |
| Gabiano, C | 1 |
| Galli, L | 1 |
| Caselli, D | 1 |
| Morandi, B | 1 |
| Campelli, A | 1 |
| Clerici, M | 1 |
| Gattinara, GC | 1 |
| Yeung, KT | 1 |
| Chan, M | 1 |
| Chan, CK | 4 |
| McIvor, RA | 2 |
| Berger, P | 1 |
| Pack, LL | 2 |
| Rachlis, A | 1 |
| Tamburrini, E | 1 |
| Mencarini, P | 1 |
| Visconti, E | 1 |
| Zolfo, M | 1 |
| Siracusano, A | 1 |
| Ortona, E | 1 |
| Rizzardi, GP | 1 |
| Musicco, M | 1 |
| Frigerio, D | 1 |
| Maillard, M | 1 |
| Lucchini, M | 1 |
| Moroni, M | 2 |
| Johansson, AM | 1 |
| Grankvist, KG | 1 |
| Schäfer, H | 2 |
| Pickenhain, A | 1 |
| Kaplanski, G | 1 |
| Granel, B | 1 |
| Di Stefano, D | 1 |
| Durand, JM | 1 |
| Soubeyrand, J | 1 |
| Pérez-Molina, JA | 2 |
| López-Vélez, R | 1 |
| Montilla, P | 1 |
| Guerrero, A | 2 |
| Edge, MD | 2 |
| Rimland, D | 2 |
| O'Brien, JG | 1 |
| Dong, BJ | 1 |
| Coleman, RL | 1 |
| Gee, L | 1 |
| Balano, KB | 1 |
| Gracia, JD | 1 |
| Miravitlles, M | 1 |
| Mayordomo, C | 1 |
| Ferrer, A | 1 |
| Alvárez, A | 1 |
| Bravo, C | 1 |
| Vendrell, M | 1 |
| Yoshida, EM | 1 |
| Filipenko, D | 1 |
| Phillips, P | 1 |
| Montaner, JS | 1 |
| Whittaker, JS | 1 |
| Easterbrook, PJ | 2 |
| Bucher, HC | 1 |
| Griffith, L | 1 |
| Guyatt, GH | 1 |
| Styrt, BA | 1 |
| Chaisson, RE | 2 |
| Moore, RD | 2 |
| Tabet, SR | 1 |
| Krone, MR | 1 |
| Hooton, TM | 1 |
| Koutsky, LA | 1 |
| Holmes, KK | 1 |
| Morris-Jones, SD | 1 |
| Gambini, D | 1 |
| Brambilla, AM | 1 |
| Galli, C | 1 |
| Castagna, A | 1 |
| Veglia, F | 1 |
| Gupta, M | 1 |
| Stephenson, K | 1 |
| Gauar, S | 1 |
| Frenkel, L | 1 |
| Turner, BJ | 1 |
| Markson, L | 1 |
| Cocroft, J | 1 |
| Cosler, L | 1 |
| Hauck, WW | 1 |
| Adrados, M | 1 |
| Alvar, J | 1 |
| Valencia, ME | 1 |
| Moreno, V | 1 |
| Polo, R | 1 |
| Verdejo, J | 1 |
| Jiménez, MI | 1 |
| Martínez, P | 1 |
| Martínez, ML | 1 |
| Golpe Gómez, R | 1 |
| Cifrián Martínez, JM | 1 |
| Fernández Rozas, SM | 1 |
| García Pérez, MM | 1 |
| Mons Lera, R | 1 |
| Jiménez Gómez, A | 1 |
| Wei, CC | 1 |
| Moorman, AC | 1 |
| Von Bargen, JC | 1 |
| Palella, FJ | 1 |
| Bossi, P | 1 |
| Caumes, E | 1 |
| Astagneau, P | 1 |
| Li, TS | 1 |
| Paris, L | 1 |
| Mengual, X | 1 |
| Katlama, C | 1 |
| Bricaire, F | 1 |
| Jones, JL | 1 |
| Manfredi, R | 2 |
| Salfi, N | 1 |
| Pasquinelli, G | 1 |
| Chiodo, F | 3 |
| Sackoff, J | 1 |
| McFarland, J | 1 |
| Su, S | 1 |
| Bryan, E | 1 |
| Gabriëls, G | 1 |
| Stockem, E | 1 |
| Greven, J | 1 |
| Koch, A | 1 |
| Kothe, H | 1 |
| Braun, J | 1 |
| Kämmerer, R | 1 |
| Friedrich, HJ | 1 |
| Dalhoff, K | 1 |
| Arastéh, KN | 1 |
| Simon, V | 1 |
| Musch, R | 1 |
| Weiss, RO | 1 |
| Przytarski, K | 1 |
| Futh, UM | 1 |
| Pleuger, F | 1 |
| Huhn, D | 1 |
| L'age, MP | 1 |
| Master, RJ | 1 |
| Rawji, A | 1 |
| Lee-Pack, LR | 1 |
| Favell, K | 1 |
| Taguchi, H | 1 |
| Takahashi, T | 1 |
| Wada, Y | 1 |
| Dixon, DO | 1 |
| McIntosh, M | 1 |
| Albert, JM | 1 |
| Schnittman, SM | 1 |
| Chan, C | 1 |
| Montaner, J | 1 |
| Lefebvre, EA | 1 |
| Morey, G | 1 |
| Dohn, M | 1 |
| Scott, J | 1 |
| Marina, R | 1 |
| Caldwell, P | 1 |
| Dassopoulos, T | 1 |
| Ehrenpreis, ED | 1 |
| García Vázquez, E | 1 |
| de Górgolas Hernández, M | 1 |
| García Delgado, R | 1 |
| Fernández Guerrero, ML | 1 |
| O'Riordan, T | 1 |
| Faris, M | 1 |
| Haas, C | 1 |
| Marteau, P | 1 |
| Roudière, L | 1 |
| Gisselbrecht, M | 1 |
| Lowenstein, W | 1 |
| Durand, H | 1 |
| Mussini, C | 1 |
| Pezzotti, P | 1 |
| Govoni, A | 1 |
| Borghi, V | 1 |
| d'Arminio Monforte, A | 1 |
| Mongiardo, N | 1 |
| Cerri, MC | 1 |
| Concia, E | 1 |
| Bonazzi, L | 1 |
| Ortona, L | 1 |
| Esposito, R | 1 |
| Cossarizza, A | 1 |
| De Rienzo, B | 1 |
| Robins, JM | 1 |
| Teruya, K | 1 |
| Yasuoka, A | 1 |
| Yamaguchi, M | 1 |
| Yasuoka, C | 1 |
| Yamamoto, Y | 1 |
| Genka, I | 1 |
| Tachikawa, N | 1 |
| Kikuchi, Y | 1 |
| Dorrell, L | 1 |
| McCallum, AK | 1 |
| Snow, MH | 1 |
| Cheng, B | 1 |
| Zuger, A | 1 |
| Torres, G | 1 |
| Cadman, J | 1 |
| Afeltra, J | 1 |
| Meis, JF | 1 |
| Mouton, JW | 1 |
| Verweij, PE | 1 |
| Smego, RA | 1 |
| Nagar, S | 1 |
| Maloba, B | 1 |
| Popara, M | 1 |
| Nacher, M | 1 |
| Sainte Marie, D | 1 |
| Guibert, P | 1 |
| Rabaud, C | 1 |
| Leport, C | 1 |
| Groll, AH | 1 |
| Ritter, J | 1 |
| Müller, FM | 1 |
| Kovacs, JA | 1 |
| Gill, VJ | 2 |
| Meshnick, S | 1 |
| Masur, H | 3 |
| Calza, L | 1 |
| Marinacci, G | 1 |
| Colangeli, V | 1 |
| Fortunato, L | 1 |
| Goldie, SJ | 1 |
| Kaplan, JE | 1 |
| Losina, E | 1 |
| Weinstein, MC | 1 |
| Paltiel, AD | 1 |
| Seage, GR | 1 |
| Craven, DE | 1 |
| Kimmel, AD | 1 |
| Zhang, H | 1 |
| Cohen, CJ | 1 |
| Freedberg, KA | 1 |
| Sawka, CA | 1 |
| Shepherd, FA | 1 |
| Brandwein, J | 1 |
| Burkes, RL | 1 |
| Sutton, DM | 1 |
| Warner, E | 1 |
| Schneider, MM | 1 |
| Hoepelman, AI | 1 |
| Eeftinck Schattenkerk, JK | 1 |
| van der Graaf, Y | 1 |
| Frissen, JP | 1 |
| van der Ende, IM | 1 |
| Kolsters, AF | 1 |
| Borleffs, JC | 1 |
| Medrano, FJ | 1 |
| Hernández-Quero, J | 1 |
| Jiménez, E | 1 |
| Pineda, JA | 1 |
| Sánchez-Quijano, A | 1 |
| Velez, ID | 1 |
| Viciana, P | 1 |
| Castillo, R | 1 |
| Reyes, MJ | 1 |
| Levine, SJ | 1 |
| Kennedy, D | 1 |
| Shelhamer, JH | 1 |
| Kovacs, A | 1 |
| Feuerstein, IM | 1 |
| Stock, F | 1 |
| Solomon, D | 1 |
| Boylen, CT | 1 |
| Fahy, JV | 1 |
| Chin, DP | 1 |
| Schnapp, LM | 1 |
| Steiger, DJ | 1 |
| Schaumberg, TH | 1 |
| Klein, JS | 1 |
| Keruly, J | 1 |
| Richman, DD | 1 |
| Comtois, R | 1 |
| Pouliot, J | 1 |
| Vinet, B | 1 |
| Lemieux, C | 1 |
| Suzuki, T | 1 |
| Takahashi, Y | 1 |
| Yoshida, S | 1 |
| Yamagishi, T | 1 |
| Tateyama, M | 1 |
| Tanaka, A | 1 |
| Koshihara, K | 1 |
| Matsumoto, K | 1 |
| Fukue, H | 1 |
| Yorifuji, H | 1 |
| Hardy, WD | 1 |
| Power, ME | 1 |
| Kaczka, C | 1 |
| Holmes, M | 1 |
| Waskin, H | 1 |
| Fass, RJ | 1 |
| Sha, BE | 1 |
| Benson, CA | 1 |
| Deutsch, T | 1 |
| Noskin, GA | 1 |
| Murphy, RL | 1 |
| Pottage, JC | 1 |
| Finn, WG | 1 |
| Roth, SI | 1 |
| Kessler, HA | 1 |
| Blais, FX | 1 |
| Vöhringer, HF | 1 |
| Arasteh, K | 1 |
| Link, H | 1 |
| Ehninger, G | 1 |
| Hardtmann, I | 1 |
| Slavin, MA | 1 |
| Hoy, JF | 1 |
| Stewart, K | 1 |
| Pettinger, MB | 1 |
| Lucas, CR | 1 |
| Kent, SJ | 1 |
| Kronawitter, U | 1 |
| Hanley, SP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Which Apparatus for Inhaled Pentamidine? A Comparison of Drug Delivery to the Lung Between Two Nebulizers: The Respirgard II and the Isoneb.[NCT02277808] | Early Phase 1 | 10 participants (Anticipated) | Interventional | 2013-12-31 | Recruiting | ||
| A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Pneumonia in AIDS[NCT00000715] | Phase 3 | 240 participants | Interventional | Completed | |||
| Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy[NCT00000722] | 45 participants | Interventional | Completed | ||||
| A Randomized Trial of Three Anti-Pneumocystis Agents Plus Zidovudine for the Primary Prevention of Serious Infections in Patients With Advanced HIV Infection[NCT00000991] | Phase 3 | 600 participants | Interventional | Completed | |||
| A Randomized, Open-Label Trial of High Dose Atovaquone Versus Low Dose Atovaquone Versus Aerosolized Pentamidine for Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With HIV Infection Who Are Intolerant of TMP/SMX[NCT00002340] | Phase 3 | 615 participants | Interventional | Completed | |||
| Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF: The CORRAL-AF Study[NCT04684212] | 2,931 participants (Anticipated) | Interventional | 2023-12-01 | Not yet recruiting | |||
| A Controlled Comparative Trial of Trimethoprim - Sulfamethoxazole Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)[NCT00000727] | Phase 3 | 322 participants | Interventional | Completed | |||
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites[NCT00000826] | Phase 1 | 48 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
31 reviews available for pentamidine and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Drug Therapy, Com | 2010 |
[Diagnosis and treatment of pneumocystis jirovecii pneumonia].
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Broncho | 2011 |
[Pneumocystis carinii pneumonia].
Topics: AIDS-Related Opportunistic Infections; Bronchoalveolar Lavage Fluid; Humans; Immunocompromised Host; | 2003 |
Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antiprotozoal Agents; Antire | 2002 |
Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Bone Marrow Transplantation; Humans; Immun | 2004 |
A background and critical analysis of the treatment of pneumocystis carinii pneumonia (PCP) in HIV/AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Anti-Inflammatory Agents; Antiprotozoa | 2007 |
Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review.
Topics: AIDS-Related Opportunistic Infections; Clindamycin; Cohort Studies; Humans; Pentamidine; Pneumocysti | 2008 |
Torsade de pointes and elevated magnesium and calcium requirements associated with intravenous pentamidine.
Topics: Adult; AIDS-Related Opportunistic Infections; Electrocardiography; Humans; Hypocalcemia; Infusions, | 1994 |
Human immunodeficiency virus infection in children.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Dapsone; Didanosine; Dru | 1995 |
Pancreatic lesions in HIV-infected patients.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Didanosine; HIV Infections; Humans; Pancreas; | 1994 |
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; | 1995 |
The use of intravenous immunoglobulins in symptomatic HIV infection. Results of a randomized study.
Topics: AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Combined Modality Therapy; HIV In | 1994 |
Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antimony; | 1994 |
[An atrioventricular block secondary to pentamidine treatment].
Topics: AIDS-Related Opportunistic Infections; Heart Block; HIV-1; Humans; Male; Middle Aged; Pentamidine; P | 1994 |
Recommendations for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Antipneumocystis Prophylaxis in Patients with Human Immunodeficiency Virus Infection.
Topics: AIDS-Related Opportunistic Infections; Clinical Trials as Topic; HIV Infections; Humans; Pentamidine | 1993 |
Acute respiratory failure due to Pneumocystis carinii pneumonia.
Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Diagnosis, Differential; Health Pers | 1993 |
Pneumocystis carinii thyroiditis. Report of three cases and review of the literature.
Topics: Adult; AIDS-Related Opportunistic Infections; Humans; Male; Pentamidine; Pneumocystis Infections; Pn | 1993 |
A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
Topics: AIDS-Related Opportunistic Infections; Dapsone; Dose-Response Relationship, Drug; Humans; Logistic M | 1996 |
Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; | 1995 |
[Therapy and prevention of pneumocystis carinii pneumonia].
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Atovaquone; Clindamycin; Clinical | 1995 |
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Ag | 1996 |
Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifunga | 1997 |
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal | 1997 |
Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
Topics: Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Child; Clindamycin; Drug Ther | 1997 |
[Hyperkalemia after trimethoprim or pentamidine. Until now, a little noticed side effect of antimicrobial therapeutic measures in AIDS patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiprotozoal Agents; Folic Acid Antag | 1998 |
[Pneumocystis carinii pneumonia].
Topics: AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents; Diagnosis, Differential; Drug Thera | 1999 |
Acute pancreatitis in human immunodeficiency virus-infected patients: a review.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Didano | 1999 |
Inhaled antimicrobial therapy.
Topics: Administration, Inhalation; Aerosols; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; | 1999 |
A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Clindamycin | 2001 |
[Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer].
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infectiv | 2001 |
Prevention and treatment of pneumocystis pneumonia.
Topics: AIDS-Related Opportunistic Infections; Humans; Pentamidine; Pneumonia, Pneumocystis; Trimethoprim, S | 1992 |
36 trials available for pentamidine and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Effects of aerosolized pentamidine on glucose homeostasis and insulin secretion in HIV-positive patients: a controlled study.
Topics: Administration, Inhalation; Adult; Aerosols; AIDS-Related Opportunistic Infections; C-Peptide; Cross | 1995 |
Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aerosols; AIDS-Related Opportunistic Infections; Dapsone; | 1995 |
Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Double-Blind Method; Female; Huma | 1995 |
Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Double-Blind Method; Female; Huma | 1995 |
Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Double-Blind Method; Female; Huma | 1995 |
Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Double-Blind Method; Female; Huma | 1995 |
Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; Animals; Dapsone; Drug Adm | 1995 |
Administration of pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS.
Topics: Administration, Inhalation; Adolescent; Adult; AIDS-Related Opportunistic Infections; Drug Therapy, | 1995 |
Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Digestive System; Drug Therapy, Combinati | 1995 |
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Topics: Administration, Oral; Adult; Aerosols; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; | 1995 |
The role of atovaquone tablets in treating Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; | 1995 |
Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Female; Humans; Male; M | 1994 |
The use of intravenous immunoglobulins in symptomatic HIV infection. Results of a randomized study.
Topics: AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Combined Modality Therapy; HIV In | 1994 |
Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity.
Topics: Absenteeism; Acquired Immunodeficiency Syndrome; Adult; Aerosols; AIDS-Related Opportunistic Infecti | 1994 |
Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Dapsone; Encephalitis; Female; Humans; Male; | 1993 |
Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Combination; Female; Follow-Up | 1994 |
Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a controlled, randomized trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aerosols; Aged; AIDS-Related Opportunistic Infections; CD | 1993 |
Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Female; Follow-Up Studies; HIV Infections; H | 1994 |
Prophylaxis of aerosolized pentamidine-induced bronchospasm: a symptom-based approach.
Topics: Administration, Inhalation; Adult; Aerosols; AIDS-Related Opportunistic Infections; Bronchial Spasm; | 1993 |
A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; AIDS-Related Opportunistic Infections; Drug Administra | 1993 |
Prophylaxis of Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Drug Therapy, Combination; Humans; Pentamidine; Pneumonia, Pn | 1993 |
Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Dapsone; Drug Therapy, Co | 1993 |
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Topics: Adult; AIDS-Related Complex; AIDS-Related Opportunistic Infections; Dapsone; Drug Combinations; Ence | 1993 |
Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aerosols; Aged; AIDS-Related Opportunistic | 1995 |
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Infe | 1995 |
Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic human immunodeficiency virus infection. The Italian Pediatric Collaborative Study Group on Pentamidi
Topics: Adolescent; Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Child; Child, Presch | 1996 |
Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Female; HIV-1; Humans; Male; Pentamidine; Pn | 1996 |
Intrapulmonary and systemic pharmacokinetics of aerosolized pentamidine used for prophylaxis of pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Bronchoscopy; Female; Hum | 1995 |
Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Child; | 1997 |
Clinic HIV-focused features and prevention of Pneumocystis carinii pneumonia.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; AIDS-Related Opportunistic Infections; Anti | 1998 |
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agent | 1998 |
Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaq | 1999 |
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Age | 2000 |
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; AIDS-Related Opportunistic Infections; Algorithms; Ant | 2000 |
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; AIDS-Related Opportunistic Infections; Algorithms; Ant | 2000 |
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; AIDS-Related Opportunistic Infections; Algorithms; Ant | 2000 |
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; AIDS-Related Opportunistic Infections; Algorithms; Ant | 2000 |
Bactrim approved for prophylaxis.
Topics: Adult; AIDS-Related Opportunistic Infections; Humans; Pentamidine; Pneumonia, Pneumocystis; Trimetho | 1994 |
Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; | 1992 |
A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
Topics: Adult; Aerosols; Aged; AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes; Drug Admin | 1992 |
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Female; Follow-Up Studies; Humans; Male; Pentamidin | 1992 |
Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity.
Topics: Administration, Intranasal; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Bloo | 1992 |
137 other studies available for pentamidine and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Synthesis and DNA interactions of benzimidazole dications which have activity against opportunistic infections.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Base Sequence; Benzimidazoles; Binding Sit | 1996 |
Case Report: Intravenous Pentamidine Rescue Treatment for Active Chronic Visceral Leishmaniasis in an HIV-1 Infected Patient.
Topics: Administration, Intravenous; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Coinfectio | 2021 |
Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Cohort Studies; Female; Humans; | 2015 |
Splenic pneumocystosis: an atypical presentation of extrapulmonary Pneumocystis infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Atovaquone; Female | 2008 |
[Raised tattoos in a human-immunodeficiency-virus-infected patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral | 2009 |
Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; HIV- | 2009 |
Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; | 2009 |
Breakthrough Pneumocystis jiroveci pneumonia under pentamidine prophylaxis: imaging findings revisited.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic | 2009 |
Pulmonary nocardiosis caused by Nocardia exalbida complicating Pneumocystis pneumonia in an HIV-infected patient.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle | 2011 |
Fatal bilateral pneumothoraces following administration of aerosolised pentamidine.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Antifungal Agents; Asthma; Forens | 2011 |
Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Asia; CD4 Lymphocy | 2012 |
[Use of pentamidine nebulization in children].
Topics: Adolescent; AIDS-Related Opportunistic Infections; Antifungal Agents; Child; Child, Preschool; HIV-1 | 2012 |
AIDS-related Pneumocystis carinii pneumonia with disappearance of cystic lesions after treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Bronchoalveolar Lavage; Bronchos | 2002 |
Aerosolized pentamidine prophylaxis against AIDS-related Pneumocystis carinii pneumonia and its short- and long-term effects on pulmonary function in the Japanese.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Female; Humans; Lung; | 2003 |
Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Case-Control Studies; CD4 | 2004 |
An HIV-positive man with tattoo induration.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle | 2007 |
Health insurance and utilization in Pneumocystis carinii pneumonia.
Topics: Adult; AIDS-Related Opportunistic Infections; Bronchoscopy; California; Female; HIV-1; Humans; Insur | 1995 |
Acute severe autonomic insufficiency during pentamidine therapy.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Autonomic Nerv | 1995 |
Pentamidine concentrations in a mother with AIDS and in her neonate.
Topics: Adult; AIDS-Related Opportunistic Infections; Female; Humans; Infant, Newborn; Male; Pentamidine; Pn | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Treatment of visceral leishmaniasis in a patient with AIDS with antimony and gamma-interferon: remission and prevention of relapse by maintenance therapy with weekly pentamidine.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Drug Administration Sc | 1995 |
Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Therapy, Combination; Fees, Pharmaceutic | 1994 |
Respiratory effects of occupational exposure to aerosolized pentamidine.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Air Pollutants, Occupational; Airway Resista | 1995 |
Pentamidine-induced derangements of glucose homeostasis. Determinant roles of renal failure and drug accumulation. A study of 128 patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Diabetes Mellitus; Female; Humans; Hyperglycemia; Hypo | 1995 |
Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Dapsone; HIV Infections; HIV-1; | 1995 |
Aerosolized pentamidine prophylaxis of Pneumocystis carinii pneumonia.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Clinical Trials as Topic; Humans; Pentamidine; Pneu | 1995 |
Insulin-dependent diabetes mellitus following pentamidine therapy in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Diabetes Mellitus, Type 1; Humans; Male; Middle Aged; Pentami | 1994 |
Does the choice of Pneumocystis carinii prophylaxis influence the prevalence of Enterocytozoon bieneusi microsporidiosis in AIDS patients?
Topics: AIDS-Related Opportunistic Infections; Animals; Cohort Studies; Feces; Humans; Microsporida; Microsp | 1995 |
[Macroscopic hematuria secondary to the administration of intravenous pentamidine].
Topics: Adult; AIDS-Related Opportunistic Infections; Female; Hematuria; Humans; Injections, Intravenous; Pe | 1995 |
Resistance to trimethoprim-sulfamethoxazole and sensitivity to pentamidine therapy in an AIDS patient with hepatosplenic pneumocytosis.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Drug Resistance, Microbial; Homosexuality, M | 1994 |
[Prevention of Pneumocystis carinii pneumonia associated with HIV infection using pentamidine aerosols. Retrospective study of 465 cases].
Topics: Adult; Aerosols; Aged; AIDS-Related Opportunistic Infections; Female; Humans; Male; Middle Aged; Pat | 1994 |
CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Child; Child, | 1994 |
Primary prophylaxis against opportunistic infections in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Clotrimazole; Dapsone; Fluconazole; Humans; Mycoses; Pentamid | 1995 |
Safety of pentamidine prophylaxis for Pneumocystis carinii pneumonia on the endocrine pancreatic function in HIV patients.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; HIV Infections; HIV Seropositivity; Humans; | 1994 |
Diabetes mellitus following intravenous pentamidine administration in a patient with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Diabetes Mellitus; Humans; Male; Pentamidine; Pneumoni | 1995 |
Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Candidiasis; CD4-Positive | 1993 |
Effect of pentamidine on the growth of Cryptococcus neoformans.
Topics: AIDS-Related Opportunistic Infections; Candida albicans; Cryptococcosis; Cryptococcus neoformans; Hu | 1994 |
[Pulmonary pneumocystosis revealing HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Female; HIV Infect | 1994 |
Detection of Pneumocystis carinii in urinary samples from a patient with AIDS despite prophylactic treatment with aerosolized pentamidine.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Bacteriuria; Fatal Outcome; Female; Humans; | 1994 |
Failure of pentamidine as prophylaxis for Pneumocystis carinii pneumonia in HIV-infected children.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Child, Preschool; Drug Therapy, Combina | 1994 |
[Pneumonia caused by Pneumocystis carinii in immunodepressed patients: clinical picture, treatment, and prognosis].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Female; Follow-Up Studies; Humans; Immunoc | 1994 |
Decreased efficacy of inhaled pentamidine in the prevention of Pneumocystis carinii pneumonia among HIV-infected patients with severe immunodeficiency.
Topics: Acquired Immunodeficiency Syndrome; Administration, Inhalation; Adult; AIDS-Related Opportunistic In | 1993 |
Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocyte | 1993 |
[Extrapulmonary intrathoracic pneumocystosis. Apropos of 4 cases in HIV positive patients].
Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; CD4-Positive T-Lymphocytes | 1993 |
Probable pentamidine-induced acute pancreatitis.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Humans; Male; Methylprednisolone; Pancr | 1994 |
Aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia: what is the correct dose?
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Dose-Response Relationship, Drug; Humans; Ma | 1994 |
Aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in infants with human immunodeficiency virus infection.
Topics: Aerosols; AIDS-Related Opportunistic Infections; HIV Infections; Humans; Infant; Pentamidine; Pneumo | 1994 |
Pneumocystis carinii pneumonia presenting as focal bibasilar uptake on gallium scan during aerosolized pentamidine prophylaxis.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Gallium Radioisotopes; Humans; Lung; Male; P | 1994 |
[Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations].
Topics: Administration, Inhalation; Adult; Aerosols; AIDS-Related Opportunistic Infections; Female; Follow-U | 1994 |
Pneumocystis carinii infections in HIV-infected hemophiliacs during aerosolized pentamidine prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; AIDS-Related Opportunistic Infections; Hemophilia A; H | 1993 |
Contact urticaria from pentamidine isethionate.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Dermatitis, Occupa | 1993 |
[Hypoglycemia secondary to intravenous pentamidine treatment without subsequent diabetes mellitus].
Topics: Adult; AIDS-Related Opportunistic Infections; Humans; Hypoglycemia; Injections, Intravenous; Male; P | 1993 |
Administration of aerosolized pentamidine to HIV-infected infants.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Humans; Infant; Pentamidine; Pneumonia, Pneumocysti | 1993 |
[Protozoan infections in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Administration, Inhalation; AIDS-Related Opportunistic Infection | 1993 |
The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacterial Infections; Cohort Studies; Female; HIV Infe | 1993 |
Pneumocystis carinii choroidopathy and aerosolized pentamidine prophylaxis in a patient with AIDS.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Choroiditis; Eye Infections, Fungal; Humans; | 1993 |
Understanding prophylactic therapy for HIV infections.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Cytomegalovirus Infections; Dru | 1994 |
Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Arrhythmias, Cardiac; Cohort Studies; Dose-Respo | 1994 |
Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiviral Agents; Bisexua | 1993 |
Transient state of NIDDM in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Blood Glucose; C-P | 1993 |
Diagnostic utility of lactate dehydrogenase levels in patients receiving aerosolized pentamidine.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Clinical Enzyme Tests; Humans; L-Lactate Deh | 1993 |
Bronchoscopy versus empirical therapy in HIV-infected patients with presumptive Pneumocystis carinii pneumonia. A decision analysis.
Topics: AIDS-Related Opportunistic Infections; Biopsy; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; | 1993 |
[Spontaneous pneumothorax disclosing isolated pleural involvement caused by Pneumocystis carinii in an AIDS patient].
Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; Humans; Male; Pentamidine; | 1993 |
Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiviral Agents; Cohort Studies; Daps | 1993 |
Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
Topics: Administration, Inhalation; Aerosols; AIDS-Related Opportunistic Infections; Child, Preschool; Dapso | 1993 |
Increased Pneumocystis carinii recovery from the upper lobes in Pneumocystis pneumonia. The effect of aerosol pentamidine prophylaxis.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Bronchoalveolar Lavage Fluid; Humans; Lung; Pentami | 1993 |
Intramuscular pentamidine for the prevention of Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Female; Humans; Injections, Intramuscular; M | 1993 |
Cholestatic giant cell hepatitis associated with ultrastructural evidence of intrahepatic retroviral infection in a human immunodeficiency virus-seropositive infant.
Topics: AIDS-Related Opportunistic Infections; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; | 1993 |
A novel variety of atypical Pneumocystis carinii infection after long-term prophylactic pentamidine inhalation in an AIDS patient: large lower lobe pneumocystoma.
Topics: Administration, Inhalation; Adult; AIDS-Related Opportunistic Infections; Humans; Male; Pentamidine; | 1993 |
Chronic pentamidine aerosol prophylaxis does not induce QT prolongation.
Topics: Administration, Inhalation; Adult; Aerosols; AIDS-Related Opportunistic Infections; Cross-Sectional | 1993 |
Effects of aerosolized pentamidine in AIDS patients.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Humans; Pentamidine; Pneumonia, Pneumocystis | 1993 |
Prevention and treatment of Pneumocystis pneumonia.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Humans; Pentamidine; Pneumonia, Pneumocystis; Trime | 1993 |
Lack of effect of prophylactic aerosolized pentamidine on the detection of Pneumocystis carinii in induced sputum or bronchoalveolar lavage specimens.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Bronchoalveolar Lavage Fluid; Humans; Pentamidine; | 1993 |
[Extrapulmonary and disseminated pneumocystosis in HIV infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Bone Marrow Diseases; Female; HIV Infections; Humans; | 1993 |
Predictive value of bronchoalveolar lavage in excluding a diagnosis of Pneumocystis carinii pneumonia during prophylaxis with aerosolized pentamidine.
Topics: Administration, Intranasal; Adult; Aerosols; AIDS-Related Opportunistic Infections; Bronchoalveolar | 1993 |
Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia.
Topics: Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Dexamethasone; Drug Therapy, | 1995 |
Acute hepatic and renal failure caused by Pneumocystis carinii in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Fatal Outcome; Female; Humans; Live | 1995 |
Pentamidine-induced hyperglycemia and ketosis in acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Diabetic Ketoacidosis; Fatal Outcom | 1995 |
[Extra-pulmonary pneumocystosis in the course of AIDS. Report of a case].
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Bronchoalveolar Lavage Fluid; Femal | 1996 |
[Pneumocystis carinii pneumonia in AIDS: retrospective analysis of 80 documented cases (1985-1993)].
Topics: Adult; Aerosols; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agen | 1996 |
The safety of i.v. pentamidine administered in an ambulatory setting.
Topics: Adult; AIDS-Related Opportunistic Infections; Ambulatory Care; Cost Savings; Humans; Infusions, Intr | 1996 |
An effectiveness community-based clinical trial of Respirgard II and Fisoneb nebulizers for Pneumocystis carinii prophylaxis with aerosol pentamidine in HIV-infected individuals. Toronto Aerosol Pentamidine Study (TAPS) Group.
Topics: Adult; Aerosols; Aged; AIDS-Related Opportunistic Infections; Female; Humans; Male; Middle Aged; Neb | 1996 |
Imbalance between Pneumocystis carinii cysts and trophozoites in bronchoalveolar lavage fluid from patients with pneumocystosis receiving prophylaxis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Bronchoalveo | 1996 |
Pentamidine-induced free radical toxicity to isolated islet cells.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Cells, Cultured; Free Radicals | 1996 |
Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia.
Topics: Administration, Inhalation; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; D | 1996 |
Pleural pseudotumoral mass revealing an extrapulmonary Pneumocystis carinii infection.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Diagnosis, Differential; | 1996 |
Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Pentam | 1996 |
[Improved prognosis of first episode HIV associated Pneumocystis carinii pneumonia without preventive treatment: etiology and sequelae].
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Cause of Death; Eflornithine; Female | 1996 |
Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Community-Acquired | 1996 |
A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia.
Topics: Adult; Adverse Drug Reaction Reporting Systems; AIDS-Related Opportunistic Infections; Antifungal Ag | 1997 |
Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifung | 1997 |
AIDS-related extrapulmonary Pneumocystis carinii infection presenting as a solitary rectal ulcer.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Biopsy; Humans; Male; Pen | 1996 |
Secondary prophylaxis for visceral leishmaniasis in HIV-infected individuals.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Pentam | 1997 |
How to interpret an overview: a meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Clinical Trials as Topic; Dapsone; Dat | 1997 |
Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacteremia; Case-Control Studie | 1997 |
Bacterial infections in adult patients hospitalized with AIDS: case-control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Inf | 1997 |
Increased hyperglycaemia during cotreatment with pentamidine and corticosteroids in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; | 1997 |
Visceral leishmaniasis in patients infected with the human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Allopurinol; Amebicides; Amphotericin B; Analysis of Variance | 1997 |
[Spontaneous pneumothorax associated with human immunodeficiency virus (HIV) infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drainage; Female; HIV Infection | 1998 |
Effects of long-term aerosol pentamidine for Pneumocystis carinii prophylaxis on pulmonary function.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; HIV Seropositivit | 1998 |
Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.
Topics: Adult; AIDS-Related Opportunistic Infections; Ambulatory Care; Anti-Infective Agents; Antifungal Age | 1998 |
[Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Antibodies, Protozoan; | 1998 |
Drugs for AIDS/HIV: assessing the evidence.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Bias; Clinical Protocols; | 1998 |
[Lymph node dissemination of a serious Pneumocystis carinii respiratory infection in AIDS: histopathological and ultrastructural aspects].
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Lymph | 1998 |
Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Algorithms; Anti-HIV Agen | 1998 |
[Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; CD4 Lymphocy | 1998 |
Sensitivity and specificity of indirect immunofluorescence and Grocott-technique in comparison with immunocytology (alkaline phosphatase anti alkaline phosphatase = APAAP) for the diagnosis of Pneumocystis carinii in broncho-alveolar lavage (BAL).
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Bronchoalveolar Lavage Fluid; Diagn | 1998 |
Pneumocystis pneumonia in a prepaid care system caring for a Medicaid-covered population with AIDS.
Topics: AIDS-Related Opportunistic Infections; Boston; Humans; Male; Managed Care Programs; Medicaid; Outcom | 1996 |
Lack of desensitization to aerosol pentamidine with long-term use.
Topics: Administration, Inhalation; Adult; Aerosols; AIDS-Related Opportunistic Infections; Albuterol; Antif | 1996 |
Pentamidine-induced hemolytic anemia in an AIDS patient.
Topics: AIDS-Related Opportunistic Infections; Anemia, Hemolytic; Antifungal Agents; Humans; Male; Middle Ag | 1999 |
Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Controlled Clinical Trials as Topic; D | 1999 |
Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Dapsone; Humans; Pe | 1999 |
[Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; A | 1999 |
[Severe cytomegalovirus enteritis in AIDS. Favorable outcome of medical treatment].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Celiac Disease; Cytomegalovirus Infec | 2000 |
Complications during clinical courses of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 2001 |
IV pentamidine prophylaxis for PCP.
Topics: AIDS-Related Opportunistic Infections; Humans; Injections, Intravenous; Patient Compliance; Pentamid | 1995 |
Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents | 1995 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as To | 1995 |
A difficult case of PCP.
Topics: AIDS-Related Opportunistic Infections; Female; Humans; Pentamidine; Pneumonia, Pneumocystis; Treatme | 1995 |
Optimizing PCP therapy.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; CD4 Lymphocyte Count | 1997 |
Prevention of invasive aspergillosis in AIDS by sulfamethoxazole.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Aspergillosis; Aspergillus flavus; Asp | 2001 |
Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Confidence Intervals; French Guiana; Hu | 2001 |
[Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole].
Topics: AIDS-Related Opportunistic Infections; Drug Eruptions; Drug Therapy, Combination; Follow-Up Studies; | 1998 |
New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Algorithms; Anti-Infective Agents; Atovaquone; Dihydropteroat | 2001 |
Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous | 2001 |
Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; CD4 | 2002 |
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Topics: Adult; AIDS-Related Opportunistic Infections; Allopurinol; Antiprotozoal Agents; CD4-Positive T-Lymp | 1992 |
Diagnosis of Pneumocystis carinii pneumonia by multiple lobe, site-directed bronchoalveolar lavage with immunofluorescent monoclonal antibody staining in human immunodeficiency virus-infected patients receiving aerosolized pentamidine chemoprophylaxis.
Topics: Administration, Inhalation; Adult; Aerosols; AIDS-Related Opportunistic Infections; Biopsy; Bronchoa | 1992 |
Effect of aerosolized pentamidine prophylaxis on the clinical severity and diagnosis of Pneumocystis carinii pneumonia.
Topics: Administration, Inhalation; Adult; Aerosols; AIDS-Related Opportunistic Infections; Cohort Studies; | 1992 |
Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Topics: Acquired Immunodeficiency Syndrome; Actuarial Analysis; AIDS-Related Opportunistic Infections; Case- | 1992 |
High pentamidine levels associated with hypoglycemia and azotemia in a patient with Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Humans; Hypoglycemia; Male; Middle Aged; Pentamidine; Pneumon | 1992 |
[HIV-1 seropositive hemophilia A complicated by disseminated intravascular coagulation syndrome and acute pancreatitis during treatment of Pneumocystis carinii pneumonia].
Topics: Adolescent; AIDS-Related Opportunistic Infections; Disseminated Intravascular Coagulation; Hemophili | 1992 |
Pneumocystis carinii choroiditis in patients with AIDS: clinical features, response to therapy, and outcome.
Topics: Adult; AIDS-Related Opportunistic Infections; Choroiditis; Eye; Female; Humans; Male; Pentamidine; P | 1992 |
Managing a patient with progressive HIV disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; HIV Infections; Humans; Pentamidine; T | 1992 |
[Determinants of serum pentamidine concentration in the human].
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Bone Marrow Transplantation; Dose | 1992 |
Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks.
Topics: Administration, Inhalation; Adult; Aged; AIDS-Related Opportunistic Infections; Drug Administration | 1992 |
Bronchial responsiveness in AIDS patients with Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Bronchoconstrictio | 1992 |